Natlizumab and breast cancer in situ Patient Reports September 09, 2010

Natlizumab Side Effects Report #5506864-2
Natlizumab side effect was reported by a Physician from UNITED STATES on Oct 23, 2007. Female patient, 52 years of age, weighting 156.0 lb, was diagnosed with multiple sclerosis  and was treated with Natlizumab. After drug was administered, patient experienced the following side effects: breast cancer in situ. Natlizumab dosage: unknown. During the same period patient was treated with PHENOBARBITAL, PROZAC, PROVIGIL, ADVIL. Patient recovered.